Evidence map›Paper›PMID 27432829›Full record

ArticleJournal of bacteriology2016

Chimeric Coupling Proteins Mediate Transfer of Heterologous Type IV Effectors through the Escherichia coli pKM101-Encoded Conjugation Machine.

Neal Whitaker, Trista M Berry, Nathan Rosenthal, Jay E Gordon, Christian Gonzalez-Rivera, Kathy B Sheehan, Hilary K Truchan, Lauren VieBrock, Irene L G Newton, Jason A Carlyon and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of bacteriology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. mBio · 2026
    Article
  3. Article
  4. Conjugative delivery of toxin genesJournal of bacteriology · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Neal WhitakerDepartment of Microbiology and Molecular Genetics, McGovern Medical School, Houston, Texas, USA.
Trista M BerryDepartment of Microbiology and Molecular Genetics, McGovern Medical School, Houston, Texas, USA.
Nathan RosenthalDepartment of Microbiology and Molecular Genetics, McGovern Medical School, Houston, Texas, USA.
Jay E GordonDepartment of Microbiology and Molecular Genetics, McGovern Medical School, Houston, Texas, USA.
Christian Gonzalez-RiveraDepartment of Microbiology and Molecular Genetics, McGovern Medical School, Houston, Texas, USA.
Kathy B SheehanDepartment of Biology, Indiana University, Bloomington, Indiana, USA.
Hilary K TruchanDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, School of Medicine, Richmond, Virginia, USA.
Lauren VieBrockDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, School of Medicine, Richmond, Virginia, USA.
Irene L G NewtonDepartment of Biology, Indiana University, Bloomington, Indiana, USA.
Jason A CarlyonDepartment of Microbiology and Immunology, Virginia Commonwealth University Medical Center, School of Medicine, Richmond, Virginia, USA.
Peter J ChristieDepartment of Microbiology and Molecular Genetics, McGovern Medical School, Houston, Texas, USA Peter.J.Christie@uth.tmc.edu.
Virginia Commonwealth University Medical Center · USIndiana University Bloomington · US

Funding

TRANSLOCATION OF DNA ACROSS THE AGROBACTERIUM ENVELOPER01GM048746 · NIGMS · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CHRISTIE, PETER J. · 1998 to 2018
$6.9M
Molecular Basis of Infectious Diseases Training GrantT32AI055449 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI LORENZ, MICHAEL C · 2005 to 2025
$2.6M
Structure-function analyses of bacterial Type IV secretion system subassembliesF32AI114182 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI GONZALEZ-RIVERA, CHRISTIAN · 2014 to 2016
$143k
NIAID NIH HHS F32 AI114182NIAID NIH HHS T32 AI055449NIGMS NIH HHS R01 GM048746
6 · The paper itself

Abstract

unlabelledBacterial type IV secretion systems (T4SSs) are composed of two major subfamilies, conjugation machines dedicated to DNA transfer and effector translocators for protein transfer. We show here that the Escherichia coli pKM101-encoded conjugation system, coupled with chimeric substrate receptors, can be repurposed for transfer of heterologous effector proteins. The chimeric receptors were composed of the N-terminal transmembrane domain of pKM101-encoded TraJ fused to soluble domains of VirD4 homologs functioning in Agrobacterium tumefaciens, Anaplasma phagocytophilum, or Wolbachia pipientis A chimeric receptor assembled from A. tumefaciens VirD4 (VirD4At) mediated transfer of a MOBQ plasmid (pML122) and A. tumefaciens effector proteins (VirE2, VirE3, and VirF) through the pKM101 transfer channel. Equivalent chimeric receptors assembled from the rickettsial VirD4 homologs similarly supported the transfer of known or candidate effectors from rickettsial species. These findings establish a proof of principle for use of the dedicated pKM101 conjugation channel, coupled with chimeric substrate receptors, to screen for translocation competency of protein effectors from recalcitrant species. Many T4SS receptors carry sequence-variable C-terminal domains (CTDs) with unknown function. While VirD4At and the TraJ/VirD4At chimera with their CTDs deleted supported pML122 transfer at wild-type levels, ΔCTD variants supported transfer of protein substrates at strongly diminished or elevated levels. We were unable to detect binding of VirD4At's CTD to the VirE2 effector, although other VirD4At domains bound this substrate in vitro We propose that CTDs evolved to govern the dynamics of substrate presentation to the T4SS either through transient substrate contacts or by controlling substrate access to other receptor domains. IMPORTANCE: Bacterial type IV secretion systems (T4SSs) display striking versatility in their capacity to translocate DNA and protein substrates to prokaryotic and eukaryotic target cells. A hexameric ATPase, the type IV coupling protein (T4CP), functions as a substrate receptor for nearly all T4SSs. Here, we report that chimeric T4CPs mediate transfer of effector proteins through the Escherichia coli pKM101-encoded conjugation system. Studies with these repurposed conjugation systems established a role for acidic C-terminal domains of T4CPs in regulating substrate translocation. Our findings advance a mechanistic understanding of T4CP receptor activity and, further, support a model in which T4SS channels function as passive conduits for any DNA or protein substrates that successfully engage with and pass through the T4CP specificity checkpoint.

Indexed as

Recombinant Fusion ProteinsConjugation, GeneticDNA, BacterialEscherichia coliEscherichia coli ProteinsGene Expression Regulation, BacterialProtein DomainsType IV Secretion SystemsDNA, BacterialEscherichia coli ProteinsRecombinant Fusion ProteinsType IV Secretion Systems

Identifiers

PMID27432829
PMCPMC5019051
OpenAlexW2501815460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.